2nd Annual Accelerating Clinical Trials in Asia 2018

2018年9月19-20日 • 新加坡, One Farrer Hotel & Spa

概要

Accelerating Clinical Trials in Asia是在新加坡举办的唯一以企业高层为对象的活动。本学会以临床实验的Operational excellence为主题,针对近年急速成长的亚太地区临床实验市场的业务面及实务面的重要课题进行讨论。本活动均衡涵盖了制药业界支出领域与成长部门的相关商业视角信息,是个珍贵机会,可以获得加速临床开发的高CP值方法的有用提示。

"Good networking opportunities with amazing people in the industry. This is my first conference and looking forward for more."
Nur Farhana Muhamad, Market Analyst, Pharmaniaga Berhad

本次学会的重点

  • 世界各国制药公司支出领域与亚洲临床实验市场相关计画
  • 各国政府的状况─奖励政策、投资、合作机会
  • 建立与 KOL 的关系─介绍临床实验实施计画中列出的价值
  • 技术和分析方法─对实务和临床实验的影响
  • 品质、法规遵从性和审核─案例研究和实例
  • 确保预算、择定实验实施设施和专案管理─与外部组织的有效合作

同时举行的活动

11th Annual Pharma Regulatory Affairs Summit 2018 >>
2nd Annual Pharma Market Access and Pricing Summit Asia >>
Digital Pharma >>

议程

8:00 am

Registration and Networking Session

PHARMACON ASIA OPENING PLENARY SESSION

9:00 am

Addressing on skilled talent, strong manufacturing capabilities and thriving research ecosystem in pharmaceutical firms to set up to serve patients and connect with the growing Asian market.

9:30 am

[Industry Address] Integrating Silicon with Drugs: Pushing the Boundaries of Pharma Manufacturing with Digital Medicines

Nik Leist, Senior Director, Ingestible Sensor Manufacturing/Site Leader, Proteus Digital Health, USA

10:40 am

Morning Networking and Refreshment Break

End of opening Plenary and 2nd Annual Clinical Trials in Asia Commence

11:10 am

Chairperson's Opening Remarks

TECH IN TRIALS

11:15 am

  • How are digital platforms shaping clinical trials operations?
  • How can we use digital platforms to improve and accelerate clinical trials?
  • Leveraging AI for a paradigm shift in clinical research
  • Patient engagement and the democratisation of clinical trial information
  • Cutting - edge technology to match the right patients with the right trials

11:45 am

  • Intelligent trials - the Road to successfully operating trials in digital platforms
  • Harnessing the power of data intelligence
  • Challenges and opportunities in clinical trials operations
  • Embracing change - organisation-wide and partner management
  • Future of clinical trials modernization in Asia

12:30 pm

Digitally Enabled Trials Should not be the Exception but the Norm

Robert Kerle, Senior Director, Clinical Operations, Asia Pacific, IQVIA

1:00 pm

Networking Lunch

2:00 pm

  • Enabling digital workflow throughout trial process
  • Improving patient enrollment and engagement
  • Smart decisions based on data-driven facts
  • Improving outcomes for patients and R&D

CLINICAL TRIAL MARKETS

2:30 pm

  • What is "Investigator-led" oncology trials compared to the traditional pharma sponsored trials?
  • Examples of some of the "Investigator-led" oncology trials
  • Value of "Investigator-led" oncology trials for society

3:30 pm

Afternoon Networking and Refreshment Break

4:00 pm

  • Business case of approval and hospital permit highlights
  • Providing support / cooperation (funding, sponsored drugs/ medications)
  • Patient and subjects: Demography, Recruitment
  • The role of local coordinator: overcoming language and cultural barrier
  • Step by step approach in succeeding in Indonesia

4:30 pm

  • Challenges and opportunities for clinical research in Malaysia
  • Advantage in investigations, patient population, infrastructure
  • Facilities, infrastructure and personnel in healthcare system
  • Ethical concerns, approval process and regulations for clinical research
  • Clinical research leaders' recruitment expertise
  • Optimizing patient recruitment
  • Best practices that can be used to ensure patients' compliance
  • Best practices in selecting clinical research sites

5:30 pm

Chairperson's Summary of the Day and End of Conference Day 1

9:00 am

Chairperson's Opening Remarks

OPTIMISING TRIAL OUTCOMES

9:05 am

Japan- Pioneering Patient Centricity Initiative -Valuable Insights

Dr. Norie Miki-Yasuda, Head of Japan Clinical Operations Division. Janssen Pharmaceutical K.K., Japan

10:10 am

  • Framework of good practices for global project management
  • Managing external and internal teams
  • Stakeholder management through CROs
  • Overall outsourcing project Management

10:40 am

Morning Networking and Refreshment Break

11:10 am

CRO's Perspective: Digitalisation Impact Areas - Trial Design, Patient Recruitment, Patient Centricity, Site Monitoring, Big Data Analytics, Cloud Based Clinical Data Warehouses

11:40 am

  • Conditional approval – an emerging as a paradigm to speed up drug development and accessibility to new critical treatments
  • Key merits and criticalities of this approach

DISEASE SPECIFIC TRIALS

12:10 pm

Moving Beyond Immuno-Oncology: a small molecule strategy

Harish Dave, Co-Founder and Chief Medical Officer, Aum Biosciences, Singapore

12:30 pm

Networking Lunch

1:30 pm

  • History of therapy (laser and injections)
  • Intravitreal and Subtenon delivery of medications (Triamcinolone, Bevacizumab, Aflibercept)
  • Anatomical and Functional Success
  • Our experience in conducting clinical trials

2:00 pm

Case Study in Infectious Disease Using Molecular Endpoints to Accelerate Clinical Trials through the Development of Molecular Endpoints

Raphael Zellweger, Scientific Director, The Viral Research and Experimental Medicine Centre @ SingHealth Duke-NUS (ViREMiCS)

INNOVATION IN CRITICAL TREATMENT TRIALS

2:30 pm

  • Opportunity and business expansion
  • Regulatory challenges and applications
  • Technology and site selection
  • Cost control and managing project
  • Case study

3:00 pm

  • Speeding up studies with eTMF Systems
  • Trial Management when TMF subcontracted to CRO
  • Organising TMF when the trial is multi-country or multi-centre
  • Trial data storage, security and quality

3:30 pm

Afternoon Networking and Refreshment Break

CLOSING PLENARY SESSION

4:10 pm

  • Top line innovation trends and implications
  • Drug research and development environment in the long term
  • Impact of M&A activity and investment on industry
  • Emerging pharma business models, broadening value propositions, and sustainable revenue models

5:00 pm

Chairperson's Summary of the Day and End of Conference

* 活动内容有可能不事先告知作更动及调整。

赞助商募集

参加成为Accelerating Clinical Trials in Asia的夥伴,可提高知名度。
利用本活动成为引领市场的企业、确保地位,可发挥各种机会进行品牌行销与市场行销。请联系我们以了解更多信息。

演讲者

Ho Weng Si

Director, Biomedical Sciences Group, Economic Development Board, Singapore

Nik Leist

Senior Director, Ingestible Sensor Manufacturing/Site Leader, Proteus Digital Health, USA

Enver Erkan

Country Manager, Pfizer Singapore

Alexis Serlin

Asia Cluster Head, Novartis

Miguel Angel Rivera Tapia

Global Digital Innovation Lead, Ferring Pharmaceuticals, Switzerland

How Ti-Hwei

Country President, AstraZeneca, Singapore

Pablo Graiver

Co-founder & CEO, Antidote, United Kingdom

Clarence Khoo

Associate Director, Clinical Operations, Takeda Development Center (Asia)

Ajay Tiku

Region Medical Head, Asia Pacific, Middle East and Africa (APMA), Novartis

Dennis Teng

JAPAC Immunology Gastro TA Assoc. Director AbbVie, Singapore

Robert Kerle

Senior Director, Clinical Operations, Asia Pacific, IQVIA

Fuqu Wang

Director, R&D Operations Innovation Leader, The Janssen Pharmaceutical, United States

Teoh Yee Leong

Chief Executive Officer, Singapore Clinical Research Institute

Hazel Dy Tioco

Asia Pacific Regional Director, Study Management and Logistics, Sanofi, Philippines

Dr. Martin Hertanto

Dept. of Ophthalmology, Faculty of Medicine Universitas Indonesia

Tah Pei Chien

Principal Investigator, University Malaya Medical Centre, Malaysia

Naresh Gupta

M.D., Director- Professor, Maulana Azad Medical College, Chief, Haemophilia Centre &Network Coordinator for Haemophilia, India, Principal Investigator, Maulana Azad Medical College & Lok Nayak Hospital

Dr. Anggun Ramayudantha

Vitreoretina Specialist and Lecturer in Dept. of Ophthalmology, Faculty of Medicine Universitas Indonesia

Dr. Norie Miki-Yasuda

Head of Japan Clinical Operations Division. Janssen Pharmaceutical K.K., Japan

Alex Goh

Head, Regional Clinical Quality and Medical Quality, Asia Pacific, GSK, Singapore

Sow Wei Wong

Legal Counsel Takeda Global Research & Development Centre (Asia)

Ning Xu

Executive Vice President, Head of Clinical and Regulatory, ZaiLab, China

Yongho Oh

Regional Clinical PM and ISS PM for Asia, JPAC & China, Sanofi Pasteur, Singapore

Vincenzo Teneggi

Senior Medical Director, D3 (Drug Discover & Development) A*STAR, Singapore

Harish Dave

Co-Founder and Chief Medical Officer, Aum Biosciences, Singapore

Raphael Zellweger

Scientific Director, The Viral Research and Experimental Medicine Centre @ SingHealth Duke-NUS (ViREMiCS)

Yaron Turpaz

Chief Data & Technology Officer, Managing Director, Global Gene Corp, Singapore

活动日期与地点

2018年9月19-20日

新加坡, One Farrer Hotel & Spa
1 Farrer Park Station Road
Singapore 217562

Contact Person: Daniel Koh
DDI: (+65) 6705 7884
Fax: (+65) 6834 7892
Cell: (+65) 86870123
Email: danielkoh@onefarrer.com

赞助商

展商

合作夥伴

Media Partners

APBN serves as a knowledge exchange platform (print and online) to provide latest news and noteworthy information in biotechnology, healthcare, biomedical and pharmaceutical industry in Asia Pacific. Established in 1997, APBN is the first and only monthly magazine focused on biotechnology, healthcare, pharmaceutical and life science developments in China and other Asia Pacific countries. The main motivation of APBN is to bring biotechnology news in a comprehensive and concise manner to, but not limited to, clinicians, research scientists, students, and other industry professionals and experts.

Bentham Science Publishers is rendering a vital service in the quality publication that publishes over 100 peer-reviewed print and online scientific, technical and medical journals. These titles are indexed in recognized indexing agencies, such as Science Citation Index®, Journal Citation Reports/Science Edition, MEDLINE/Index Medicus, PubMed, Scopus, Chemical Abstracts, EMBASE etc. Some of the high impact titles which enjoy a wide reach and distribution are Current Gene Therapy (Impact Factor 4.906), Current Alzheimer Research (Impact Factor 3.796), Current Medicinal Chemistry (Impact Factor 3.715), and other popular titles.

Bentham has an extensive library of eBooks in the areas of science, technology, medicine, social sciences and humanities. Bentham eBooks publishes monographs, handbooks, conference proceedings, textbooks, review volumes, biographies and autobiographies.

Established since 1998, Bio-Equip is a leading website for lab equipments, reagents, consumables and bio services. Our users come from different fields like life science, medical research, pharmaceutical, biotechnology, modern agriculture, food safety and environment monitoring. Bio-Equip offer users a complete product directory which involves 158 product ranges among lab equipments, reagents, consumables, lab animals, bio services, cell lines, bio software and books.Serving users through two websites, www.bio-equip.com (Chinese) and www.bio-equip.cn (English), we own over 20,000 registered suppliers and more than 500,000 pieces of product and technical service information with details of product description, price, sample downloading, technical articles and videos.

BiotechEast provides information and services related to Taiwan's growing life science industries. Our services cover a wide scope, including marketing and business intelligence, investment sourcing, and partner identification and vetting. Founded in 2003, our mission is connecting Taiwan and overseas companies within this industry space, for the advancement of medical technology and the benefit of patients everywhere.

KONGPOSH Publications is one of the leading Pharma publishers of India. Our publications are - The Pharma Review® is a bi-monthly article based journal. Covering news, views and articles on various fields of pharmacy including Clinical Trials, Biotechnology, Review/Research papers, Herbal Medicine and much more. Contributions received from Eminent pharma personalities from India as well as other countries which helps us to have a varied and rich content matter. Participation and distribution in over 20 Expos & Conferences worldwide each year. It is widely read by decision makers, middle management and the academia. The journal is Abstracted & Indexed in International Pharmaceutical Abstract & Chemical Abstract - USA, Index Copernicus - Poland & Ulrich's Journal Database- USA for the quality of its content. Also available on our website and E-book format.

For regular complimentary link of the journal write to us on kongposhpub@gmail.com.

 

SOURCE newswire provides comprehensive coverage of breaking news for the life sciences industry in China. Daily updates allow timely tracking of key company developments, deal-making, and regulatory trends, with the primary focus on the pharmaceutical industry.

  • Daily News Briefs: receive 3-4 original articles each day
  • Email alerts on topics of interest by keyword.
  • Access a fully searchable archive of 20,940 original articles
  • Filter news by story type: company news; product/R&D trends; pricing and reimbursement decisions; and general policy developments
  • Ability to save and share favorite news items.

Lingmed Ltd was founded in 2013 in Hong Kong, currently we have offices in Shanghai and Beijing. Lingmed promotes three leading intelligence databases for healthcare professionals in China to make better decisions. Lingmed’s core products are healthcare intelligence databases; it covers global innovative assets & China market intelligence. Lingmed’s Products and Services have been recognized by Fortune 500 multinational pharma and device companies as well as Chinese local big pharmacos. In addition, we together with our partners in Europe provide partnering services to bridge European and Chinese pharmaceuticals with biotech companies, including valuation and market monitoring reports.

 

In the realm of Pharmacy, where innovation is rapid, Pharmaceutical-Tech stands adept at conceptualizing unique ideas relevant to the B2B space. Pharmaceutical-Tech is essentially a B2B online business, technology media platform and global magazine that have under its wraps the largest global database of Pharmacy buyers and suppliers. Pharmaceutical-Tech.com covers in-depth trends that shape industry dynamics and metamorphose global economics. With services like search engine optimization, global magazine, social media marketing, product video showcase, e-mail marketing, e-newsletter sponsorship, banner advertising, event marketing and micro-website within our platform, www.pharmaceutical-tech.com has created a recognition that spans over a global audience, thereby revolutionizing how businesses transact.

Pharma China (www.pharmachinaonline.com) is the most trusted English media and business intelligence service covering the Chinese pharmaceutical / biopharmaceutical industry and market.

Pharma China caters for the growing needs of the international pharmaceutical industry for up-to-date and insightful information and intelligence on China's burgeoning but increasingly complex healthcare marketplace, and is subscribed by most multinational pharmaceutical companies, leading CROs, investment banks and consulting firms active in China as well as relevant industry associations and government agencies.

  • Pharma China Journal Edition (monthly in PDF and Print)
  • Pharma China Web Edition (continuously-updated news, in-depth commentaries and online databases)
  • China Pharmaceutical Guide (the most comprehensive and authoritative reference for China's healthcare sector)

Pharma Focus Asia is a quarterly magazine from Ochre Media Pvt. Ltd. Pharma Focus Asia covers important issues and trends shaping the future of the Pharma industry across Asia and rest of the world. It is the leading Pharma title in print as well as digital versions serving the information needs of key executives from the world's leading pharmaceutical companies.

Informa's Pharma Intelligence is the trusted partner of the top 50 global pharmaceutical companies and the top 10 contract research organisations (CRO's) – providing timely intelligence and insight to help them make authoritative decisions.

From drug and device discovery and development to regulatory approval, drug reimbursement to lifecycle management – we provide the global intelligence and insight to help advance our partners' initiatives in a fast changing market.

Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide.

Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique online Showcase Profiling & Discover services, as well as its renowned Partnering Search service leveraging its global network of industry experts, to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing is actively utilized by many tens of thousands of industry professionals each month. Pharmalicensing is a division of IP Technology Exchange, Inc.

Technology Networks scientific communities offer today's scientists a single resource that contains unique, engaging, and entertaining content from their field of research.

 

免费电子邮件通知服务